Cargando…
Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes
BACKGROUND: An “obesity paradox” for mortality has been shown in chronic disorders such as diabetes, and attributed to methodological bias, including the use of body mass index (BMI) for obesity definition. This analysis investigated the independent association of BMI versus surrogate measures of ce...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716975/ https://www.ncbi.nlm.nih.gov/pubmed/36461034 http://dx.doi.org/10.1186/s12933-022-01706-2 |
_version_ | 1784842805489696768 |
---|---|
author | Orsi, Emanuela Solini, Anna Penno, Giuseppe Bonora, Enzo Fondelli, Cecilia Trevisan, Roberto Vedovato, Monica Cavalot, Franco Lamacchia, Olga Haxhi, Jonida Nicolucci, Antonio Pugliese, Giuseppe |
author_facet | Orsi, Emanuela Solini, Anna Penno, Giuseppe Bonora, Enzo Fondelli, Cecilia Trevisan, Roberto Vedovato, Monica Cavalot, Franco Lamacchia, Olga Haxhi, Jonida Nicolucci, Antonio Pugliese, Giuseppe |
author_sort | Orsi, Emanuela |
collection | PubMed |
description | BACKGROUND: An “obesity paradox” for mortality has been shown in chronic disorders such as diabetes, and attributed to methodological bias, including the use of body mass index (BMI) for obesity definition. This analysis investigated the independent association of BMI versus surrogate measures of central adiposity with all-cause mortality in individuals with type 2 diabetes. METHODS: The Renal Insufficiency And Cardiovascular Events Italian Multicentre Study is a prospective cohort study that enrolled 15,773 patients in 19 Italian centres in 2006–2008. Exposures were BMI and the surrogate measures of central adiposity waist circumference (WC), waist-to-height ratio (WHtR), and A Body Shape Index (ABSI). Vital status was retrieved on 31 October 2015 for 15,656 patients (99.3%), RESULTS: Age- and sex-adjusted hazard ratios and 95% confidence intervals were significantly higher in BMI-based underweight (1.729 [1.193–2.505), P = 0.004), moderately obese (1.214 [1.058–1.392), P = 0.006) and severely obese (1.703 [1.402–2.068), P < 0.0001), lower in overweight (0.842 [0.775–0.915), P < 0.0001) and similar in mildly obese (0.950 [0.864–1.045), P = 0.292), compared to normal-weight individuals. When further adjusting for smoking, physical activity (PA), and comorbidities, risk was lower also in mildly obese versus normal-weight patients. The BMI-mortality relationship did not change after sequentially excluding ever smokers, individuals with comorbidities, and those died within two years from enrollment and when analyzing separately participants below and above the median age. Conversely, a paradox relationship was observed among inactive/moderately inactive, but not moderately/highly active patients. Mortality risk adjusted for age, gender, smoking, PA and comorbidities was significantly higher in the highest tertile of WC (1.279 [1.089–1.501], P = 0.003), WHtR (1.372 [1.165–1.615], P < 0.0001), and ABSI (1.263 [1.067–1.495], P = 0.007) versus the lowest tertile. However, risk was lower in the intermediate versus lowest tertile for WC (0.823 [0.693–0.979], P = 0.028), similar for WHtR, and higher, though not significantly, for ABSI. CONCLUSIONS: An “overweight paradox” remained after controlling for age, smoking, and comorbidities, arguing against a collider bias or reverse causation. However, it could be partly explained by confounding from PA level, possibly through its impact on lean mass and cardiorespiratory fitness. No obesity paradox was observed with WHtR and especially ABSI, which predicted mortality risk associated with central adiposity better than WC. Trial registration ClinicalTrials.gov, NCT00715481, 15 July, 2008 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-022-01706-2. |
format | Online Article Text |
id | pubmed-9716975 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-97169752022-12-03 Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes Orsi, Emanuela Solini, Anna Penno, Giuseppe Bonora, Enzo Fondelli, Cecilia Trevisan, Roberto Vedovato, Monica Cavalot, Franco Lamacchia, Olga Haxhi, Jonida Nicolucci, Antonio Pugliese, Giuseppe Cardiovasc Diabetol Research BACKGROUND: An “obesity paradox” for mortality has been shown in chronic disorders such as diabetes, and attributed to methodological bias, including the use of body mass index (BMI) for obesity definition. This analysis investigated the independent association of BMI versus surrogate measures of central adiposity with all-cause mortality in individuals with type 2 diabetes. METHODS: The Renal Insufficiency And Cardiovascular Events Italian Multicentre Study is a prospective cohort study that enrolled 15,773 patients in 19 Italian centres in 2006–2008. Exposures were BMI and the surrogate measures of central adiposity waist circumference (WC), waist-to-height ratio (WHtR), and A Body Shape Index (ABSI). Vital status was retrieved on 31 October 2015 for 15,656 patients (99.3%), RESULTS: Age- and sex-adjusted hazard ratios and 95% confidence intervals were significantly higher in BMI-based underweight (1.729 [1.193–2.505), P = 0.004), moderately obese (1.214 [1.058–1.392), P = 0.006) and severely obese (1.703 [1.402–2.068), P < 0.0001), lower in overweight (0.842 [0.775–0.915), P < 0.0001) and similar in mildly obese (0.950 [0.864–1.045), P = 0.292), compared to normal-weight individuals. When further adjusting for smoking, physical activity (PA), and comorbidities, risk was lower also in mildly obese versus normal-weight patients. The BMI-mortality relationship did not change after sequentially excluding ever smokers, individuals with comorbidities, and those died within two years from enrollment and when analyzing separately participants below and above the median age. Conversely, a paradox relationship was observed among inactive/moderately inactive, but not moderately/highly active patients. Mortality risk adjusted for age, gender, smoking, PA and comorbidities was significantly higher in the highest tertile of WC (1.279 [1.089–1.501], P = 0.003), WHtR (1.372 [1.165–1.615], P < 0.0001), and ABSI (1.263 [1.067–1.495], P = 0.007) versus the lowest tertile. However, risk was lower in the intermediate versus lowest tertile for WC (0.823 [0.693–0.979], P = 0.028), similar for WHtR, and higher, though not significantly, for ABSI. CONCLUSIONS: An “overweight paradox” remained after controlling for age, smoking, and comorbidities, arguing against a collider bias or reverse causation. However, it could be partly explained by confounding from PA level, possibly through its impact on lean mass and cardiorespiratory fitness. No obesity paradox was observed with WHtR and especially ABSI, which predicted mortality risk associated with central adiposity better than WC. Trial registration ClinicalTrials.gov, NCT00715481, 15 July, 2008 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-022-01706-2. BioMed Central 2022-12-02 /pmc/articles/PMC9716975/ /pubmed/36461034 http://dx.doi.org/10.1186/s12933-022-01706-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Orsi, Emanuela Solini, Anna Penno, Giuseppe Bonora, Enzo Fondelli, Cecilia Trevisan, Roberto Vedovato, Monica Cavalot, Franco Lamacchia, Olga Haxhi, Jonida Nicolucci, Antonio Pugliese, Giuseppe Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes |
title | Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes |
title_full | Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes |
title_fullStr | Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes |
title_full_unstemmed | Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes |
title_short | Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes |
title_sort | body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716975/ https://www.ncbi.nlm.nih.gov/pubmed/36461034 http://dx.doi.org/10.1186/s12933-022-01706-2 |
work_keys_str_mv | AT orsiemanuela bodymassindexversussurrogatemeasuresofcentraladiposityasindependentpredictorsofmortalityintype2diabetes AT solinianna bodymassindexversussurrogatemeasuresofcentraladiposityasindependentpredictorsofmortalityintype2diabetes AT pennogiuseppe bodymassindexversussurrogatemeasuresofcentraladiposityasindependentpredictorsofmortalityintype2diabetes AT bonoraenzo bodymassindexversussurrogatemeasuresofcentraladiposityasindependentpredictorsofmortalityintype2diabetes AT fondellicecilia bodymassindexversussurrogatemeasuresofcentraladiposityasindependentpredictorsofmortalityintype2diabetes AT trevisanroberto bodymassindexversussurrogatemeasuresofcentraladiposityasindependentpredictorsofmortalityintype2diabetes AT vedovatomonica bodymassindexversussurrogatemeasuresofcentraladiposityasindependentpredictorsofmortalityintype2diabetes AT cavalotfranco bodymassindexversussurrogatemeasuresofcentraladiposityasindependentpredictorsofmortalityintype2diabetes AT lamacchiaolga bodymassindexversussurrogatemeasuresofcentraladiposityasindependentpredictorsofmortalityintype2diabetes AT haxhijonida bodymassindexversussurrogatemeasuresofcentraladiposityasindependentpredictorsofmortalityintype2diabetes AT nicolucciantonio bodymassindexversussurrogatemeasuresofcentraladiposityasindependentpredictorsofmortalityintype2diabetes AT pugliesegiuseppe bodymassindexversussurrogatemeasuresofcentraladiposityasindependentpredictorsofmortalityintype2diabetes AT bodymassindexversussurrogatemeasuresofcentraladiposityasindependentpredictorsofmortalityintype2diabetes |